News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lewis Karen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $86, valued at
$430k
Exercised 5,000 options to buy
@ $34.11, valued at
$170.6k
|
|
| 04/05/2023 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $75, valued at
$375k
Exercised 5,000 options to buy
@ $34.11, valued at
$170.6k
|
|
| 02/27/2023 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 1,104 shares
@ $68.76, valued at
$75.9k
|
|
| 02/22/2023 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 6,628 shares
@ $0
Paid exercise price by delivering 553 shares
@ $58.5, valued at
$32.4k
Granted 9,402 options to buy
@ $35.46, valued at
$333.4k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 367 shares
@ $52.77, valued at
$19.4k
|
|
| 01/25/2023 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Sold 2,955 shares
@ $51.58, valued at
$152.4k
|
|
| 01/24/2023 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,411 shares
@ $52.05, valued at
$73.4k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 434 shares
@ $38.59, valued at
$16.7k
|
|
| 01/25/2022 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 17,466 shares
@ $0
Granted 24,774 options to buy
@ $35.46, valued at
$878.5k
|
|
| 02/01/2021 |
4
| Lewis Karen (Chief People Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 1,250 shares
@ $0
Granted 30,000 options to buy
@ $44.9, valued at
$1.3M
Granted 7,500 options to buy
@ $44.9, valued at
$336.8k
|
|
|
|